Isolated Transaminitis in Duchenne Muscular Dystrophy Infant
- Elevated liver enzymes, specifically isolated transaminitis (abnormal alanine aminotransferase or aspartate aminotransferase levels without other liver disease indicators), can sometimes be an early, unexpected sign of Duchenne Muscular...
- A recent case report details an instance where an infant presented with isolated transaminitis as the initial clinical finding.
- The underlying mechanism involves muscle damage caused by the dystrophin deficiency characteristic of DMD.
Isolated Transaminitis: An Early Indicator of Duchenne Muscular Dystrophy in Infants
Table of Contents
Published September 13, 2025
Understanding the Connection
Elevated liver enzymes, specifically isolated transaminitis (abnormal alanine aminotransferase or aspartate aminotransferase levels without other liver disease indicators), can sometimes be an early, unexpected sign of Duchenne Muscular Dystrophy (DMD) in infants. This connection is increasingly recognized as crucial for prompt diagnosis and potential intervention. DMD is a genetic disorder primarily affecting males, characterized by progressive muscle weakness and degeneration.
Case study highlights
A recent case report details an instance where an infant presented with isolated transaminitis as the initial clinical finding. Further investigation, prompted by the unusual liver enzyme elevation, ultimately led to the diagnosis of DMD. This underscores the importance of considering neuromuscular disorders in the differential diagnosis of unexplained liver enzyme abnormalities in young children, notably boys.
The underlying mechanism involves muscle damage caused by the dystrophin deficiency characteristic of DMD. When muscle fibers break down, cellular contents, including enzymes like creatine kinase and possibly contributing to liver enzyme elevations, are released into the bloodstream. While not all infants with DMD will exhibit transaminitis, its presence should raise a clinical suspicion.
Why Early Detection Matters
Early diagnosis of DMD is critical because emerging therapies, such as exon-skipping drugs and gene therapy, are most effective when initiated before meaningful muscle damage has occurred. Identifying the condition through an atypical presentation like isolated transaminitis allows for timely genetic testing and potential access to these treatments. Delays in diagnosis can result in irreversible muscle loss and a diminished quality of life.
Clinical Implications and Recommendations
Healthcare professionals should be aware of the potential link between isolated transaminitis and DMD, especially in male infants. If unexplained elevated liver enzymes are detected, a thorough evaluation, including a detailed family history, physical examination focusing on neurological and muscular function, and consideration of creatine kinase levels, is warranted. Genetic testing for dystrophin gene mutations should be pursued if clinical suspicion is high.
This case highlights the importance of a broad differential diagnosis and vigilance in pediatric care. Recognizing atypical presentations of genetic disorders can considerably improve patient outcomes.
